Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases
Open accessThe DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.
Abstract
Maintenance of healthy human metabolism depends on a symbiotic consortium among bacteria, archaea, viruses, fungi, and host eukaryotic cells throughout the human gastrointestinal tract. Microbial communities provide the enzymatic machinery and the metabolic pathways that contribute to food digestion, xenobiotic metabolism, and production of a variety of bioactive molecules. These include vitamins, amino acids, short-chain fatty acids (SCFAs), and metabolites, which are essential for the interconnected pathways of glycolysis, the tricarboxylic acid/Krebs cycle, oxidative phosphorylation (OXPHOS), and amino acid and fatty acid metabolism. Recent studies have been elucidating how nutrients that fuel the metabolic processes impact on the ways immune cells, in particular, macrophages, respond to different stimuli under physiological and pathological conditions and become activated and acquire a specialized function. The two major inflammatory phenotypes of macrophages are controlled through differential consumption of glucose, glutamine, and oxygen. M1 phenotype is triggered by polarization signal from bacterial lipopolysaccharide (LPS) and Th1 proinflammatory cytokines such as interferon-γ, TNF-α, and IL-1 β, or both, whereas M2 phenotype is triggered by Th2 cytokines such as interleukin-4 and interleukin-13 as well as anti-inflammatory cytokines, IL-10 and TGF β, or glucocorticoids. Glucose utilization and production of chemical mediators including ATP, reactive oxygen species (ROS), nitric oxide (NO), and NADPH support effector activities of M1 macrophages. Dysbiosis is an imbalance of commensal and pathogenic bacteria and the production of microbial antigens and metabolites. It is now known that the gut microbiota-derived products induce low-grade inflammatory activation of tissue-resident macrophages and contribute to metabolic and degenerative diseases, including diabetes, obesity, metabolic syndrome, and cancer. Here, we update the potential interplay of host gut microbiome dysbiosis and metabolic diseases. We also summarize on advances on fecal therapy, probiotics, prebiotics, symbiotics, and nutrients and small molecule inhibitors of metabolic pathway enzymes as prophylactic and therapeutic agents for metabolic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to regulation of infection and commensal spread, microbiome-immune interactions are implicated in a variety of ‘non-communicable’ gastrointestinal diseases including inflammatory bowel disease (IBD)8 and celiac diseases,9 as well as extra-intestinal disorders ranging from rheumatic arthritis,10 metabolic syndrome,11 neurodegenerative disorder12 to malignancy.13”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [11]
In the citing paper
“Changes in this microbial equilibrium that is, dysbiosis can promote and influence the course of many intestinal and extra-intestinal diseases[14-16].”
From Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified (2019) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 2×
“Several important questions on the complex interaction between host and microbes in pathophysiology of obesity remain answered [49, 74, 75].”
BackgroundA human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · cited 2×
“Several important questions on the complex interaction between host and microbes in pathophysiology of obesity remain answered [49, 74, 75].”
BackgroundEnterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 2×
“Unstimulated macrophages displaying M0 phenotype and exhibiting the differentiation surface markers CD68/ CD80//CD206 acquire and display the M1 phenotype (CD68/CD80//CD206) or M2 phenotype (CD68/ CD80/CD206/) after switching their metabolism and function in response to stimuli or polarization signals that initiate a…”
BackgroundThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 1×
“Initial clues for the role of microorganisms in energy homeostasis and obesity appeared from the studies using germ-free animals [76].”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Sender, R., Fuchs, S., & Milo, R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002533 · Cited by 5,425 · cited 1×
“A collection of 100-400× 10(12) of bacteria inhabits and lives in mutualistic relationships in the human GI tract [3].”
BackgroundMiller, M. B., & Bassler, B. L. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.165 · Cited by 5,105 · cited 1×
“Finally, bacteria can inhibit the growth of their competitors by long distance microbial communication, via release of metabolites and quorum sensing peptides, which are considered a biological strategy for maintenance of density of commensal species, and elimination of pathogenic bacteria [23, 24].”
Background
Cited by
Items 201–300 of 397
Ahuja, A., Dhanalekshmi, U. M., Saraswathy, M. P., Nandakumar, S., Francis, A. P., & Gurpreet, K. N. (2022) · Drug Metabolism and Bioanalysis Letters · doi:10.2174/2949681015666220615120300 · Cited by 9
Franck, M., de Toro‐Martín, J., & Vohl, M. (2022) · Evolutionary Biology · doi:10.1007/s11692-022-09569-x · Cited by 9
“Although non-human primates living in captivity can develop metabolic disorders and undergo microbiota changes similar to humans (Frankel et al., 2019; Kavanagh et al., 2013; Vemuri et al., 2022), epidemiology of MetS and CNCDs in humans tends to indicate a greater prominence of this adaptive mismatch in humans (Kones…”
BackgroundInfluentialThe Role of Diet in Shaping Gut Microbiota and Its Impact on Host Metabolic Regulation
Hernández-Valles, A. E., Martínez-Machado, G., Alvarado-Mata, L. Y., Ortíz, C. E., Nimmakayala, P., Balagurusamy, N., & Reddy, U. K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062768 · Cited by 8
“These taxa are frequently described as producers of anti-inflammatory metabolites linked to reduced inflammation and improved metabolic profiles [67,68].”
Nutrition and the state of the intestinal microflora in the formation of the metabolic syndrome
Patrakeeva, V. P., & Анатольевич, Ш. В. (2022) · Obesity and metabolism · doi:10.14341/omet12893 · Cited by 9
The Yin-Yang functions of macrophages in metabolic disorders
Bai, J., & Liu, F. (2022) · Life Medicine · doi:10.1093/lifemedi/lnac035 · Cited by 8
Zhang, D., Xu, Y., Chen, H., Wang, D., Geng, Z., Chen, Y., Chen, Y., Xiong, D., Yang, R., Liu, X., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.993501 · Cited by 8
“These biological processes can also affect the diversity of gut microbiota (64, 65).”
BackgroundRecent advances in low-level laser therapy on depression
Xu, S. S., & Wan, B. (2022) · Stress and Brain · doi:10.26599/sab.2022.9060026 · Cited by 8
Emerging therapy targets to modulate microbiome-mediated effects evident in cardiovascular disease
Hoffelner, D. K., & Hendrikx, T. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1631841 · Cited by 7
“As such, they can in fl uence processes including energy uptake, regulation of catabolic processes, metabolite balance, amino acid metabolism, carbohydrate metabolism and lipid metabolism (12, 14).”
Use of Prebiotics for Addressing Gut Dysbiosis and Achieving Healthy Gut–Brain Axis
Lasrado, L. D., & Rai, A. K. (2022) · Springer eBooks · doi:10.1007/978-981-16-8444-9_11 · Cited by 7
Batista, K. S., Cavalcante, H. C., Gomes, J. A. D. S., da Silva, L. A., Cavalcanti, N. S. D. H., Garcia, E. F., Menezes, F. N. D. D., de Lima, T. A. S., SOUZA, E. L. D., Magnani, M., et al. (2023) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202320201684 · Cited by 7
Discovery of intestinal microorganisms that affect the improvement of muscle strength
Ahn, J., Kim, H.-M., Han, E.-J., Hong, S., & Chung, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-15222-2 · Cited by 6
Ma, Y., Zhang, Y.-S., Cao, J.-X., Chen, H.-C., Su, X.-M., Li, B., Kang, Y., Gao, L., & Jing, Y.-H. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.06.026 · Cited by 6
Haghshenas, L., Banihashemi, S., Malekzadegan, Y., Catanzaro, R., Ahmadi, A. M., & Marotta, F. (2024) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v15.i5.96446 · Cited by 6
“By healing the gut surroundings and balancing the microbial population[140,141], probiotics have created a new therapeutic goal for various eye diseases[142].”
Chen, W., Bi, K., Zhang, X., Jiang, J., & Diao, H. (2020) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2020.100067 · Cited by 6
Hume‐Nixon, M., Ratu, T., Clark, S., Nguyen, C. D., Neal, E. F. G., Pell, C. L., Bright, K., Watts, E., Hart, J., Mulholland, K., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061157 · Cited by 6
Different formulation approaches to improve the survivability of probiotics in the digestive tract
Baheti, R., Mahore, J., & Patole, V. (2023) · Novel Research in Microbiology Journal · doi:10.21608/nrmj.2023.291832 · Cited by 6
Gut Microbiome and its Role in the Development of Neurological Disorder (Schizophrenia)
Ameen, A., Akram, M. N., Farooq, S., Fatima, M., Raza, H., Naz, R., Aziz, U., Aziz, M., Tahir, S., & Hussain, A. (2023) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2023175311 · Cited by 7
NASH/NAFLD-Related Hepatocellular Carcinoma: An Added Burden
Georgescu, D., Lighezan, D., Rosca, C. I., Nistor, D., Ancusa, O., Suceava, I., Iancu, M. A., & Kundnani, N. R. (2023) · Life · doi:10.3390/life14010025 · Cited by 6
“Over the past decades, gut microbiota dysbiosis has been increasingly associated with various conditions, either functional, such as irritable bowel syndrome [48,49] or organic such as atherosclerosis and hypertension [50–52] as well as metabolic syndrome and NAFLD [53,54].”
BackgroundAuguet, T., López-Dupla, M., Ramos, J., Bertran, L., Riesco, D., Aguilar, C., Ardèvol, A., Pinent, M., Sabench, F., Castillo, D. D., et al. (2022) · Processes · doi:10.3390/pr10010143 · Cited by 6
“It is well-known that intestinal microbiota-derived metabolites promote low-grade chronic inflammation of tissue-resident macrophages and are involved in diseases such as obesity, T2DM, metabolic syndrome, or cancer [28].”
BackgroundPatel, B. K., Patel, K. H., & Moochhala, S. (2023) · Clinical and Translational Discovery · doi:10.1002/ctd2.170 · Cited by 6
Chukwudozie, K. I., Agbo, M. C., Ugwu, K. O., & Ezeonu, I. M. (2021) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.15.1.29 · Cited by 6
The gut microbiota in spondyloarthritis: an update
Rodríguez, V. R., Essex, M., & Poddubnyy, D. (2025) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000001079 · Cited by 5
Williams, M. D., & Smith, L. (2025) · Microorganisms · doi:10.3390/microorganisms13030555 · Cited by 5
Role of Glial Trace Amine Associated Receptor 1 (TAAR1) and Microbiota in Schizophrenia
Tsytsarev, V., Vaganova, A. N., Volnova, A. B., Fesenko, Z. S., Getachew, B., Gainetdinov, R. R., & Tizabi, Y. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04525-5 · Cited by 5
Sharma, S., Sharma, R., & Verma, A. K. (2025) · ACS Food Science & Technology · doi:10.1021/acsfoodscitech.5c00404 · Cited by 5
Guo, Q., Wu, X., & Lin, H. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1667075 · Cited by 5
“Butyrate inhibits the activation of nuclear factor kappa B (NF-κ B) and STAT1 contributing to its anti-inflammatory effects (Belizário et al., 2018).”
Zhang, J., Ma, R., Duan, X., Ma, L., Gu, J., & Bu, D. (2026) · Microbiome · doi:10.1186/s40168-025-02331-3 · Cited by 5
“Fiber degradation is a complex and essential biochemical process within the digestive system of ruminants, influenced by fiber types [4–6], physiological conditions of the rumen [7], and the structure and functions of rumen microbiota [8, 9].”
Bolon, B. N., Uzal, F. A., & Schutten, M. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-16153-7.00009-5 · Cited by 5
The Role of Gastrointestinal Dysbiosis and Fecal Transplantation in Various Neurocognitive Disorders
Castro-Vidal, Z. A., Mathew, F., Ibrahim, A. A., Shubhangi, F., Cherian, R., Choi, H. K., Begum, A., Ravula, H. K., & Giri, H. (2024) · Cureus · doi:10.7759/cureus.72451 · Cited by 5
Fecal microbiome change in patients with ulcerative colitis after fecal microbiota transplantation
Tikunov, A. Y., Morozov, V. V., Shvalov, А. N., Bardasheva, A. V., Shrainer, E., Maksimova, O. A., Волошина, И. О., Morozova, V. V., Vlassov, V. V., & Викторовна, Т. Н. (2020) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vj20.610 · Cited by 5
Belizário, J. E., & Sircili, M. P. (2020) · BMC Veterinary Research · doi:10.1186/s12917-020-02633-8 · Cited by 5
Self-citationChen, M., Huang, K., Luo, W., Zhang, F., Gan, H., & Yang, Z. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s514189 · Cited by 4
“5,6 The impact of the gut microbiome on the body is primarily exerted through its metabolites.”
Immune dysregulation and gut microbiota: Connection to health and disease development
Boleti, A. P. D. A., Cardoso, P. H. D. O., Frihling, B. E. F., de Moraes, L. F. R. N., Nunes, E. A. C., Mukoyama, L. T. H., Biembengute, M. E. F., Melo, V. F., Morales, M., de Castro, A. P., et al. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00244 · Cited by 4
“In dysbiosis, a range of pathogenic bacteria can proliferate, establishing colonies and triggering an infectious process (Belizário et al., 2018; Gagliardi et al., 2018).”
Gut-Immune Interplay: Decoding the Microbiome’s Impact on Immunity and Diseases
Khazi, A. I., & Ahmad, A. (2025) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_1377_25 · Cited by 4
Zhu, Y., Dong, H.-C., Zhang, Y., Wang, X., Chen, J., & Wang, J. J. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i44.113017 · Cited by 4
“Metabolomic analyses revealed that key herbal compounds influence mitochondrial function, particularly by restoring tricarboxylic acid cycle flux and enhancing fatty acid β oxidation[76,77].”
Zhu, C., Liu, Y., Chen, Y., Wang, Z. X. W. M. M., Gao, Y., Xu, F., & Huang, J. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.71437 · Cited by 4
Mafra, D., Alvarenga, L., de Velasco, P. C., Manhães, L. D. M., Santana, L. D. D. S. E., & Borges, N. A. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05359-z · Cited by 4
Microbiome and metabolism: Advancements in microbiome engineering
Mavros, C. F., & Ronda, C. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100404 · Cited by 4
Gut microbiota: A potential player in psychiatric symptoms during COVID-19
Zeng, Z., & Tang, W. (2024) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2024.2342846 · Cited by 4
“This correlation has been documented in various studies (Loubinoux et al. 2002; Devkota et al. 2012; Belizário et al. 2018).”
Jalandra, R., Dhar, R., Pethusamy, K., Sharma, M., & Karmakar, S. (2022) · F1000Research · doi:10.12688/f1000research.122429.1 · Cited by 4
“Emerging novel biomarkers promise precise phylum and species discrimination, confirming evidence of microbial involvement in type 2 diabetes, obesity, metabolic disorders, IBD, and even cancer.(121)”
BackgroundTsigalou, C., Konstantinidis, T., Aloizou, A., Bezirtzoglou, E., & Tsakris, A. (2022) · Springer eBooks · doi:10.1007/978-981-19-4800-8_25 · Cited by 4
Dysfunction of the Gut Microbiome and its Onset Progression of Chronic and Mental Health Disorders
Ameen, A., Amir, A., Aziz, M. N., Irshad, A., Maryam, M., & Hayat, S. (2023) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2023175425 · Cited by 4
Locational effects on oral microbiota among long-term care patients
Tsai, F., Wang, D., Yang, C., Lin, Y., Huang, L.-J., Tsai, W.-Y., Li, C., Hsu, W.-E., Tu, H., & Hsu, M. (2022) · Journal of Oral Microbiology · doi:10.1080/20002297.2022.2033003 · Cited by 4
Helisz, P., Krupa-Kotara, K. H., Gwioździk, W., & Głogowska‐Ligus, J. (2025) · Nutrients · doi:10.3390/nu17142311 · Cited by 3
“However, there is no doubt that lifestyle—including nutrition, physical activity, as well as exposure to stressors—has a direct impact on the diversity of the human gut microbiota [3,7–9].”
Exploring gut microbiota and spinal cord injury: pathogenesis, treatment strategies and prospects
Chen, Q., Zhong, M., & Ye, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1693883 · Cited by 3
“In fl ammatory cells then release in fl ammatory cytokines, which in turn induce oxidative stress (124).”
Autoimmunity, diet and autophagy
Blaise, S. A., & Muller, S. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104040 · Cited by 3
Gut microbiota and metabolite remodeling under hypoxia compromises the intestinal barrier
Yuan, Z., Zhou, S. S., Chen, L. R., Liu, F. R., Jia, Z. Y., & Bai, J. Y. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108511 · Cited by 3
Raju, N. V., Sunny, J. S., Gideon, D. A., Sukumar, K., Riaz, S., Nawaz, S., Syed, A., Eswaramoorthy, R., Pankaj, P. K., & Parashar, A. (2023) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2023.102601 · Cited by 3
Fat-rich diet promotes microbiome-dependent ATP synthesis in sheep model
Hu, F., Gebeyew, K., Wu, Z., Chen, B., Jiao, J., Tan, Z., Tian, D., & He, Z. (2025) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-025-01214-9 · Cited by 3
“Microbial species show varying tolerances to the gastroenteric oxygen, which significantly impact microbial growth and energy production mode under regional effects [20].”
The gut microbiome, human nutrition, and immunity: visualizing the future
Luikham, S., & Bhattacharyya, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822238-6.00029-7 · Cited by 3
Biomimetic Protocells Featuring Macrophage‐Like Capture and Digestion of Protein Pathogens
Xu, X., Moreno, S., Gentzel, M., Zhang, K., Wang, D., Voit, B. I., & Appelhans, D. (2023) · Small Methods · doi:10.1002/smtd.202300257 · Cited by 3
Ancusa, O., Georgescu, D., Iurciuc, S., Georgescu, L.-A., Basa, N. S., Belei, O., & Lighezan, D. (2020) · Revista de Chimie · doi:10.37358/rc.20.5.8136 · Cited by 3
Through COVID-19 – A Systems Perspective: from Square to Circular Systems
Solomonian, L., Batson, L., Franko, C., & Waunch, A. (2020) · CAND Journal · doi:10.54434/candj.68 · Cited by 3
Engineered lysins to modulate human gut microbiome communitiesPreprint
Rodriguez, J. R. D., Lu, W., Papadopoulos, J. M., Venturelli, O. S., & Romero, P. A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.14.594189 · Cited by 3
“Altered community composition and metabolic functions of the gut microbiome in response to certain environmental factors or host dysfunctions can contribute to multiple human diseases [5], [6].”
BackgroundVaccine Safety Pharmacovigilance: Individual Causality Assessment of AEFIs
Ilardo, M. L. (2023) · Università Politecnica delle Marche (Università Politecnica delle Marche) · Cited by 3
Davies, J. J. (2023) · UEA Digital Repository (University of East Anglia) · Cited by 3
Soga, K., Yamada, S., Suzuki, Y., Kusano, Y., Kobori, I., Katayama, Y., & Tamano, M. (2025) · Internal Medicine · doi:10.2169/internalmedicine.4376-24 · Cited by 2
“Gut microbiota plays a key role in metabolic, nutritional, physiological, defense, and immune processes in the human body, and its composition is closely related to that of emerging intestinal and extraintestinal diseases (4, 5).”
Belmonte, A., Leanza, Y., Polizzi, A., Romano, A., Allegra, A., Leonardi, R. M., Panuzzo, C., & Isola, G. (2025) · Oral · doi:10.3390/oral5040101 · Cited by 2
“The gut and oral microbiota produce a vast array of metabolites that influence host physiology, immune responses, and disease progression [60,61].”
The Gastro-Intestinal Microbiota in Haematology
Moreno-Mirón, J. M., Ruiz-Argüelles, G. J., Gallardo‐Pérez, M. M., Moreno-Mirón, A., Rivera-Aguilar, A. P., & Gale, R. P. (2026) · Acta Haematologica · doi:10.1159/000550689 · Cited by 2
Wu, M., Li, H., Wang, P., He, T., Zhu, M., Qin, X., Zhang, B., Cui, M., Song, B., & He, Y. (2026) · Small · doi:10.1002/smll.73633 · Cited by 2
Antimicrobial Agents Induced Microbiome Dysbiosis Its Impact on Immune System and Metabolic Health
Anuradha, K. T., Sarada, J., Aparna, Y., & Anju, S. (2023) · Springer eBooks · doi:10.1007/978-981-99-5114-7_5 · Cited by 2
姜, 振. (2021) · Pharmacy Information · doi:10.12677/pi.2021.104026 · Cited by 2
Gut Dysbiosis in Insomnia and Diurnal Cycle
Kumar, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-6760-2_8 · Cited by 2
Interplay between gut microbiota in immune homeostasis and inflammatory diseases
Tiwari, N., Suri, M., Upadhyay, J., Ansari, M. N., & Samad, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99988-5.00016-4 · Cited by 2
INTESTINAL PARASITES-GUT MICROBIOTA INTERACTIONS: A REVIEW
Yousof, H.-A. S. A. (2023) · Journal of the Egyptian Society of Parasitology · doi:10.21608/jesp.2023.297352 · Cited by 2
An Overview of Beneficiary Effects of Prebiotics and Probiotics on Animals
(2024) · International Journal of Veterinary Science · doi:10.47278/book.cam/2024.197 · Cited by 2
Gut Microbiota: Role in Health and Disease
Bagheri, M., Zahmatkesh, A., Hussain, A., Taj, T., Ashique, S., & Mojgani, N. (2025) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-031-86065-2_1 · Cited by 2
The Effects of Short-Chain Fatty Acids in Urological Diseases
Yang, H. J., & Kim, D. S. (2022) · Urogenital Tract Infection · doi:10.14777/uti.2022.17.1.8 · Cited by 2
Nikolaeva, T. N., Kozlov, V. V., Kozhevnikova, T. N., Grigorieva, E. A., Sosnovskaya, O. Y., Борисович, Ч. С., Av, S., & Pronin, A. V. (2021) · Immunologiya · doi:10.33029/0206-4952-2021-42-4-337-345 · Cited by 2
Interplay between probiotics and prebiotics for human nutrition and health
Voss, G. B., Machado, D., Barbosa, J. C., Campos, D. A., Gomes, A., & Pintado, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89908-6.00027-3 · Cited by 2
Wu, P., Lin, T., Ho, H. J., Tseng, C., Lin, Y., Liang, S., Lee, H., Kuo, M., Hung, S., Chiu, Y., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-82652/v1 · Cited by 2
The Role of the Gut-Brain Axis in Alzheimer's Disease: A Narrative Review
Karout, L. (2022) · PDXScholar (Portland State University) · doi:10.15760/honors.1271 · Cited by 2
“GM are necessary for food digestion, metabolism, and production of molecules such as vitamins, amino acids, short-chain fatty acids (SCFAs), and metabolites (Belizario et al., 2018).”
BackgroundSerrano, A. B. F. (2022) · RIUCAM · Cited by 2
Large Association of GI Tract Microbial Community with Immune and Nervous Systems
Kazempour, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104120 · Cited by 1
Khashcha, I. I., Sozanska, M. A., Mitsoda, R. M., & Korchynska, O. O. (2024) · Reproductive health of woman · doi:10.30841/2708-8731.3.2024.306434 · Cited by 1
Environmental Stressors-Mediated Apoptosis & Autophagy Detected Through Flow Cytometry
Srivastava, M., & Pant, A. B. (2025) · Springer eBooks · doi:10.1007/978-981-97-9758-5_4 · Cited by 1
The Role of Gut Microbiota in Metabolism, Immune Response, and Metabolic Health
Yusfarani, D., Hasanah, U., Raharjeng, A. R. P., Saputra, A., Saputra, M., Mauludi, I. H., & Yap, K. E. (2025) · Jurnal Biota · doi:10.19109/biota.v11i2.25315 · Cited by 1
Prajapati, C., Nand, S., Parmar, G. R., & Singh, S. K. (2025) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-95-2104-3_14 · Cited by 1
Miková, E., Krčmářová, E., Černý, V., Sklenářová, L., Avramová, P., Protivová, E., Slunéčková, B., Akhtar, M., Věcek, J., Procházka, J., et al. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10814-w · Cited by 1
Gut microbiota and aging: intermittent fasting’s influence on gut–brain axis and systemic health
Retinasamy, T., & Shaikh, M. F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30060-8.00016-9 · Cited by 1
Hatami, S., & Issazadeh, S. A. (2025) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-95-2104-3_13 · Cited by 1
From microbes to molecules: mechanistic insights into metabolite-mediated gut inflammation
Kiran, N. S., Haldar, A., & Chatterjee, A. (2026) · Exploration of Digestive Diseases · doi:10.37349/edd.2026.1005116 · Cited by 1
Host–Microbiota Metabolic Interactions in Atherosclerosis: Oral, gut, and Blood Perspectives
Khan, I., Irfan, M., Bacha, A. S., Khan, I., Ali, Y., & Zhiqiang, L. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11054-2 · Cited by 1
Aceto, G. M., Falasca, K., Berardinucci, D., Cavallo, L., Mangiò, A., Mancuso, G., Muraro, R., Ciccocioppo, R., & Catalano, T. (2026) · Pathogens · doi:10.3390/pathogens15050548 · Cited by 1
“…mucosal barrier dysfunction and immune dysregulation, these factors contribute to the establishment of a permissive niche for opportunistic bacteria, including pathogenic E. coli , thereby facilitating bacterial persistence, translocation, and, in susceptible hosts, systemic dissemination [38,39].”
Could targeting the gut microbiome provide a novel treatment option for intermittent claudication
Park, J. M., Beckman, I., & Delaney, C. L. (2026) · Current Medical Research and Opinion · doi:10.1080/03007995.2026.2673710 · Cited by 1
“Finally, while gut dysbiosis helps drive metabolic and lipid dysregulation, insulin resistance, oxidative stress and inflammation, which are all known risk factors for atherosclerosis, atherosclerosis can in turn induce unhealthy changes in the micro-biome 12,13 .”
Psychobiotic Effects of Postbiotics in Depression, Psychosis and Mania
Rad, A. H., Houshyar, J., Alikhah, H., Moghadam, S. K., Osouli, Z., Asgharzadeh, A., Sarabi‐Aghdam, V., & Asghari, A. (2026) · Health Promotion Perspectives · doi:10.34172/hpp.44340 · Cited by 1
“155,156 Enterococcus sp. can generate dopamine in a gastrointestinal-like environment in the presence of the dopamine precursor L-3,4-dihydroxyphenylalanine (L-DOPA).”
Garza, V. A. A. (2026) · Prospherus · doi:10.63535/a1vrr838 · Cited by 1
Metabolic dysfunction and severe asthma
Dixon, A. E., & Holguín, F. (2019) · European Respiratory Society eBooks · doi:10.1183/2312508x.10023718 · Cited by 1
The Gut Microbiota and Immunity
Силивончик, Н. Н. (2021) · Рецепт · doi:10.34883/pi.2021.24.3.002 · Cited by 1
Examining the Relationship between Urinary Pathogens, Antibiotic Exposure and Urolithiasis
Bjazevic, J. (2019) · Scholarship@Western (Western University) · Cited by 1
Anti-inflammatory Components from Functional Foods for Obesity
Panchal, S. K., & Brown, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-35358-2_17 · Cited by 2
The microbiome and pregnancy complications
Fuhler, G. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818097-6.00002-x · Cited by 1
The Impact of Gut Microbiota on the Immune Response to Vaccination
Bajoria, V., Szczelkun, A., Dinse, T., van Overveld, F. J., & Rijkers, G. T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00051-6 · Cited by 1
Anju, S., Aparna, Y., Anuradha, K. T., Bramhachari, P. V., & Sarada, J. (2021) · Springer eBooks · doi:10.1007/978-981-16-3156-6_9 · Cited by 1
Investigation of the Effect of Leaky Gut on COVID-19 Clinic
Öztürk, C. E., KESKİN, B. H., İnce, N., KAYABAŞI, E., Kaya, S., Cangür, Ş., Gülhan, P. Y., & Demir, M. C. (2022) · Sağlık Bilimlerinde Değer · doi:10.33631/sabd.1082004 · Cited by 1
Skrodenytė-Arbačiauskienė, V., Butrimienė, R., Kalnaitytė, A., Bagdonas, S., Montvydienė, D., Stankevičiūtė, M., Sauliutė, G., Jokšas, K., Kazlauskienė, N., Karitonas, R., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.167696 · Cited by 1
Precision Nutrition in Allergy and Immune Function
Nel, A., & Heber, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15315-0.00005-5 · Cited by 1
Changes in the Gut Microbiome as Seen in Diabetes and Obesity
Barlow, G. M., Celly, S., & Mathur, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-46712-7_5 · Cited by 1
Sorokina, D. M., Shaidullov, I. F., Buchareb, D., Ситдиков, Ф. Г., & Ситдикова, Г. Ф. (2023) · Биологические мембраны Журнал мембранной и клеточной биологии · doi:10.31857/s0233475523060099 · Cited by 1
Why the need for microbiome? An updated perspective
Michael, O. S., Adetunji, J. B., Akinwale, E. O., Adetunji, C. O., & Soladoye, A. O. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91190-0.00002-3 · Cited by 1
Metadata
- Authors
- Belizário, J. E., Faintuch, J., & Garay-Malpartida, M.
- Affiliations
- Universidade de São Paulo (BR)
- Corresponding author
- Belizário, José E.
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2018-12-09
- Volume
- 2018
- Pages
- 1-12
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC6304917
- OpenAlex
- W2904076340
- Cited by
- 341
- References
- 101
- Citations by year
- 2026: 27 · 2025: 34 · 2024: 55 · 2023: 46 · 2022: 64 · 2021: 47 · 2020: 51 · 2019: 17
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2015/18647-6, 2007/04513-1, 312206/2016-0, 308794/2014-1, 2011/188-37)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (2015/18647-6, 2007/04513-1, 312206/2016-0, 308794/2014-1, 2011/188-37)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (2015/18647-6, 2007/04513-1, 312206/2016-0, 308794/2014-1, 2011/188-37)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- gut dysbiosis, immunometabolism, macrophage polarization, M1/M2 macrophages, short-chain fatty acids, microbial metabolites, low-grade inflammation, metabolic disorders, obesity, diabetes mellitus, metabolic syndrome, cancer, fecal microbiota transplantation, probiotics, prebiotics, symbiotics, small molecule inhibitors, host-microbe interactions
- MeSH terms
- Gastrointestinal Microbiome, Animals, Humans, Macrophages, Metabolic Diseases, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.